Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

Terminated

Phase 2 Results N/A

Summary of Purpose

This research study is designed to evaluate the safety, tolerability, and efficacy of SUN N4057 (piclozotan) in subjects with acute ischemic stroke within 9 hours of the onset of symptoms.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 October 2015.

1 Sep 2004 5 Jan 2006 1 Oct 2006 1 Jan 2007 1 Oct 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Ms. Vilma Hernandez-Mejia Tel: 201-368-5029

    hvilma@asubio.com